Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in
Status
INACTIVE
Global HQ
Tel Aviv, Israel
Countries of investment
  • Israel
  • USA
Investment stages
  • Advisory
Industries
  • HealthCare
About
CardioCore BioTelemetry, a division of Philips, is at the forefront of transforming mobile health services through cutting-edge technology and comprehensive solutions. We empower healthcare providers to seamlessly monitor and diagnose patients with cardiac and chronic conditions, enhancing patient care both within hospital settings and remotely. Our commitment to innovation ensures that clinicians have access to real-time data and insights, facilitating timely interventions and improved health outcomes. By integrating advanced analytics and user-friendly platforms, CardioCore BioTelemetry is redefining the landscape of patient monitoring and management.
Min check size
$25K
Max check size
$500K
Fund size
NPS

Investment Thesis

CardioCore is a firm focused on empowering cardiologists to transition into valuebased care.
Lead investor
Co Invest
Number of exits
Preferred contact method
Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp